{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T01:22:20Z","timestamp":1768440140054,"version":"3.49.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","semthorcardiovascsurg.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Thoracic and Cardiovascular Surgery"],"published-print":{"date-parts":[[2025]]},"DOI":"10.1053\/j.semtcvs.2025.05.002","type":"journal-article","created":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T11:08:42Z","timestamp":1747739322000},"page":"435-440","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Predictors of Recurrence Following Sublobar Resection for Clinical T1N0M0 Non-Small Cell Lung Cancer"],"prefix":"10.1053","volume":"37","author":[{"given":"Lauren","family":"Drake","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7701-2195","authenticated-orcid":false,"given":"Benny","family":"Weksler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.semtcvs.2025.05.002_bib1","unstructured":"Cancer Facts and Figures (American Cancer Society) (2025)."},{"issue":"2","key":"10.1053\/j.semtcvs.2025.05.002_bib2","first-page":"436","article-title":"High-risk features associated with recurrence in stage I lung adenocarcinoma","volume":"169","author":"Fick","year":"2025","journal-title":"J\u00a0Thorac\u00a0Cardiovasc Surg"},{"issue":"6","key":"10.1053\/j.semtcvs.2025.05.002_bib3","first-page":"489","article-title":"Lobar or sublobar resection for peripheral stage IA non-small-cell lung cancer","volume":"388","author":"Altorki","year":"2023","journal-title":"N\u00a0Engl\u00a0J\u00a0Med"},{"issue":"3","key":"10.1053\/j.semtcvs.2025.05.002_bib4","first-page":"615","article-title":"Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group","volume":"60","author":"Ginsberg","year":"1995","journal-title":"Ann\u00a0Thorac\u00a0Surg"},{"key":"10.1053\/j.semtcvs.2025.05.002_bib5","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.lungcan.2022.08.013","article-title":"Survival outcomes in a prospective randomized multicenter Phase III trial comparing patients undergoing anatomical segmentectomy versus standard lobectomy for non-small cell lung cancer up to 2 cm","volume":"172","author":"Stamatis","year":"2022","journal-title":"Lung Cancer"},{"issue":"10335","key":"10.1053\/j.semtcvs.2025.05.002_bib6","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/S0140-6736(21)02333-3","article-title":"Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802\/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial","volume":"399","author":"Saji","year":"2022","journal-title":"Lancet"},{"issue":"3","key":"10.1053\/j.semtcvs.2025.05.002_bib7","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.lungcan.2012.09.010","article-title":"Re-evaluation of the prognostic value of visceral pleura invasion in Stage IB non-small cell lung cancer using the prospective multicenter ACOSOG Z0030 trial data set","volume":"78","author":"Fibla","year":"2012","journal-title":"Lung Cancer"},{"issue":"9","key":"10.1053\/j.semtcvs.2025.05.002_bib8","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1001\/jamaoncol.2024.2491","article-title":"Recurrence of non-small cell lung cancer with visceral pleural invasion: a secondary analysis of a randomized clinical trial","volume":"10","author":"Altorki","year":"2024","journal-title":"JAMA Oncol"},{"issue":"1","key":"10.1053\/j.semtcvs.2025.05.002_bib9","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1186\/s12885-024-13139-z","article-title":"Validation of IASLC 9th edition TNM classification for lung cancer: focus on N descriptor","volume":"24","author":"Son","year":"2024","journal-title":"BMC Cancer"},{"issue":"5","key":"10.1053\/j.semtcvs.2025.05.002_bib10","article-title":"Clinical stage IA non-small cell lung cancer with occult pathologic N1 and N2 disease after segmentectomy: does a completion lobectomy justify","volume":"66","author":"Luo","year":"2024","journal-title":"Eur\u00a0J\u00a0Cardiothorac\u00a0Surg"},{"issue":"6","key":"10.1053\/j.semtcvs.2025.05.002_bib11","first-page":"2469","article-title":"Lobectomy does not confer survival advantage over segmentectomy for non-small cell lung cancer with unsuspected nodal disease","volume":"159","author":"Razi","year":"2020","journal-title":"J\u00a0Thorac\u00a0Cardiovasc Surg"},{"issue":"3","key":"10.1053\/j.semtcvs.2025.05.002_bib12","first-page":"522","article-title":"Frequency of local recurrence following segmentectomy of stage IA non-small cell lung cancer is influenced by segment localisation and width of resection margins\u00a0\u2212 implications for patient selection for segmentectomy","volume":"31","author":"Sienel","year":"2007","journal-title":"Eur\u00a0J\u00a0Cardiothorac\u00a0Surg"},{"issue":"3","key":"10.1053\/j.semtcvs.2025.05.002_bib13","first-page":"1028","article-title":"Intentional segmentectomy for clinical T1 N0 non-small cell lung cancer: survival differs by segment","volume":"111","author":"Jones","year":"2021","journal-title":"Ann\u00a0Thorac\u00a0Surg"},{"issue":"2","key":"10.1053\/j.semtcvs.2025.05.002_bib14","first-page":"570","article-title":"Outcomes of superior segmentectomy versus lower lobectomy for superior segment stage I non-small-cell lung cancer are equivalent: an analysis of 196 patients at a single, high volume institution","volume":"123","author":"Dolan","year":"2021","journal-title":"J\u00a0Surg\u00a0Oncol"},{"issue":"2","key":"10.1053\/j.semtcvs.2025.05.002_bib15","first-page":"157","article-title":"Risk factors for locoregional relapse after segmentectomy: supplementary analysis of the JCOG0802\/WJOG4607L trial","volume":"20","author":"Nakagawa","year":"2025","journal-title":"J\u00a0Thorac\u00a0Oncol: Off\u00a0Publ\u00a0Int\u00a0Assoc\u00a0Study Lung Cancer"},{"issue":"2","key":"10.1053\/j.semtcvs.2025.05.002_bib16","first-page":"372","article-title":"Risk factor analysis of locoregional recurrence after sublobar resection in patients with clinical stage IA non-small cell lung cancer","volume":"146","author":"Koike","year":"2013","journal-title":"J\u00a0Thorac\u00a0Cardiovasc Surg"},{"issue":"1","key":"10.1053\/j.semtcvs.2025.05.002_bib17","first-page":"72","article-title":"Procedure-specific risk prediction for recurrence in patients undergoing lobectomy or sublobar resection for small (<\/=2 cm) lung adenocarcinoma: an international cohort analysis","volume":"14","author":"Bains","year":"2019","journal-title":"J\u00a0Thorac\u00a0Oncol: Off\u00a0Publ\u00a0Int Assoc\u00a0Study Lung Cancer"},{"issue":"2","key":"10.1053\/j.semtcvs.2025.05.002_bib18","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S2213-2600(23)00382-X","article-title":"Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer with radiologically pure-solid appearance in Japan (JCOG0802\/WJOG4607L): a post-hoc supplemental analysis of a multicentre, open-label, phase 3 trial","volume":"12","author":"Hattori","year":"2024","journal-title":"Lancet Respir\u00a0Med"},{"issue":"1","key":"10.1053\/j.semtcvs.2025.05.002_bib19","first-page":"101","article-title":"Early-stage lung adenocarcinomas with a micropapillary pattern, a distinct pathologic marker for a significantly poor prognosis","volume":"27","author":"Miyoshi","year":"2003","journal-title":"Am\u00a0J\u00a0Surg\u00a0Pathol"},{"issue":"5","key":"10.1053\/j.semtcvs.2025.05.002_bib20","first-page":"1010","article-title":"Impact of the micropapillary component on the timing of recurrence in patients with resected lung adenocarcinoma","volume":"58","author":"Watanabe","year":"2020","journal-title":"Eur\u00a0J\u00a0Cardiothorac\u00a0Surg"},{"issue":"1","key":"10.1053\/j.semtcvs.2025.05.002_bib21","first-page":"87","article-title":"Lobectomy is associated with better outcomes than sublobar resection in spread through air spaces (STAS)-positive T1 lung adenocarcinoma: a propensity score-matched analysis","volume":"14","author":"Eguchi","year":"2019","journal-title":"J\u00a0Thorac\u00a0Oncol: Off\u00a0Publ\u00a0Int\u00a0Assoc\u00a0Study Lung Cancer"},{"issue":"5","key":"10.1053\/j.semtcvs.2025.05.002_bib22","first-page":"806","article-title":"Tumor spread through air spaces is an important pattern of invasion and impacts the frequency and location of recurrences after limited resection for small stage I lung adenocarcinomas","volume":"10","author":"Kadota","year":"2015","journal-title":"J\u00a0Thorac\u00a0Oncol: Off\u00a0Publ\u00a0Int\u00a0Assoc\u00a0Study Lung Cancer"},{"issue":"3","key":"10.1053\/j.semtcvs.2025.05.002_bib23","first-page":"935","article-title":"Segmentectomy vs lobectomy for clinical stage IA lung adenocarcinoma with spread through air spaces","volume":"112","author":"Kagimoto","year":"2021","journal-title":"Ann\u00a0Thorac\u00a0Surg"},{"issue":"1","key":"10.1053\/j.semtcvs.2025.05.002_bib24","first-page":"156","article-title":"Segmentectomy provides comparable outcomes to lobectomy for stage IA non-small cell lung cancer with spread through air spaces","volume":"35","author":"Ikeda","year":"2023","journal-title":"Semin\u00a0Thorac\u00a0Cardiovasc\u00a0Surg"},{"issue":"3","key":"10.1053\/j.semtcvs.2025.05.002_bib25","first-page":"1037","article-title":"Use and outcomes of minimally invasive lobectomy for stage I non-small cell lung cancer in the National Cancer Data Base","volume":"101","author":"Yang","year":"2016","journal-title":"Ann\u00a0Thorac\u00a0Surg"},{"issue":"10308","key":"10.1053\/j.semtcvs.2025.05.002_bib26","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/S0140-6736(21)02098-5","article-title":"Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB-IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial","volume":"398","author":"Felip","year":"2021","journal-title":"Lancet"},{"issue":"10","key":"10.1053\/j.semtcvs.2025.05.002_bib27","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/S1470-2045(22)00518-6","article-title":"Pembrolizumab versus placebo as adjuvant therapy for completely resected stage IB-IIIA non-small-cell lung cancer (PEARLS\/KEYNOTE-091): an interim analysis of a randomised, triple-blind, phase 3 trial","volume":"23","author":"O'Brien","year":"2022","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1053\/j.semtcvs.2025.05.002_bib28","first-page":"338","article-title":"Lobectomy, segmentectomy, or wedge resection for peripheral clinical T1aN0 non-small cell lung cancer: a post hoc analysis of CALGB 140503 (Alliance)","volume":"167","author":"Altorki","year":"2024","journal-title":"J\u00a0Thorac\u00a0Cardiovasc Surg"},{"issue":"8","key":"10.1053\/j.semtcvs.2025.05.002_bib29","first-page":"2400","article-title":"Margin and local recurrence after sublobar resection of non-small cell lung cancer","volume":"14","author":"El-Sherif","year":"2007","journal-title":"Ann\u00a0Surg\u00a0Oncol"},{"issue":"10","key":"10.1053\/j.semtcvs.2025.05.002_bib30","first-page":"S63","article-title":"MA03.10 Association of surgical margin distance, locoregional recurrence, and survival among patients undergoing sublobar resection in CALGB140503","volume":"19","author":"Martin","year":"2024","journal-title":"J\u00a0Thorac\u00a0Oncol"}],"container-title":["Seminars in Thoracic and Cardiovascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043067925000620?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043067925000620?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T14:25:18Z","timestamp":1768400718000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043067925000620"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025]]}},"alternative-id":["S1043067925000620"],"URL":"https:\/\/doi.org\/10.1053\/j.semtcvs.2025.05.002","relation":{},"ISSN":["1043-0679"],"issn-type":[{"value":"1043-0679","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predictors of Recurrence Following Sublobar Resection for Clinical T1N0M0 Non-Small Cell Lung Cancer","name":"articletitle","label":"Article Title"},{"value":"Seminars in Thoracic and Cardiovascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.semtcvs.2025.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}